Delivery Order SPE2DB22D9239-SPE2DB24FDJ40
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,006.42 firm fixed-price contract is for the delivery of Letairis 5 mg tablets to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the Medical Supply Chain...
- The Defense Logistics Agency, a combat logistics support agency within the Department of Defense, awarded a $2,004.28 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for 4561704288 LETAIRIS 5 MG TABLET UU 10S. The place of performance will be Park Ridge, Illinois. The period of performance is from August 2, 2023 through August 23, 2023. No set aside designation or subcontractors were identified. The delivery order was issued against an existing DLA pharmaceuticals contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $9,019.26, is for the provision of pharmaceutical products including Letairis 10 mg tablets. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31, 2025. This single-award vehicle,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,012.84 Firm Fixed Price contract is for the delivery of 4564626940 Letairis 5 mg Tablet, with a completion date of June 5, 2024. DMS Pharmaceutical Group holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at up to $499,999,999, running through December 31, 2025. This...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $75,556.44 contract is for the provision of 60 tablets of the pharmaceutical product UPTRAVI 800 MCG. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. The IDC, which is valid through November 2026,...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $9,019.26 by the Defense Logistics Agency Troop Support Medical. This order is being issued against an existing indefinite delivery contract held by DMS Pharmaceutical Group with the Defense Logistics Agency, which has a potential value of up to $5 million through December 2025. Under this order, DMS Pharmaceutical Group will provide 30 tablets of Letairis 10 mg to the Park Ridge, Illinois location of...
- The Defense Logistics Agency awarded a delivery order valued at $1,047.30 to DMS Pharmaceutical Group Inc. for 90 tablets of Letrozole 2.5 mg on December 11, 2025, with completion targeted for December 12, 2025. This firm fixed-price delivery order represents a routine pharmaceutical supply transaction issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency. The award carries no set-aside designation, indicating it was competed on an...
- This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,548.06 contract is for the delivery of UPTRAVI 1,600 MCG tablets to support the recurring medical supply needs of military healthcare facilities. This order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the...
- The U.S. Defense Logistics Agency (DLA) awarded a $25,397.84 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This order is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA, which runs through December 31, 2025. Under this vehicle, DMS Pharmaceutical Group provides a wide range of pharmaceutical products,...
- This is a $1,892.90 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order was issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA valued at up to $499,999,999, which allows the DLA to place delivery orders for a comprehensive range of pharmaceutical items to support the recurring medical supply needs...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB24FDJ40Delivery Order
This is a delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for the pharmaceutical product "LETAIRIS 5 MG TABLET UU 10S" with a ceiling value of $2,004.28. The order is issued under an existing Indefinite Delivery Contract (IDC) valued at up to $499,999,999, which allows DLA to place firm fixed-price delivery orders for a wide range of pharmaceutical items to support the recurring medical supply needs of military health facilities worldwide. This IDC, under the SPE2DB program, does not have a set-aside designation. Through this and other prime vendor contracts, DMS Pharmaceutical Group provides a vast array of medications, including both common and specialized pharmaceutical products, to support the diverse medical needs of military personnel and their dependents across various Department of Defense healthcare facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 5/6/24 |